Gold Derivatives for Cancer Treatment

Metal complexes continue to find therapeutic applications for the treatment of a wide variety of human ailments. Amongst these, gold(I) thiolates are used to treat rheutmatoid arthritis but, usually in combination with other treatment or as a last resort. New therapeutic uses of gold, both as gold(I) and gold(III), are being sought, including against cancer, the focus of the present contribution. It will be demonstrated that certain gold(I) complexes show exciting cytotoxicity profiles, rivalling those of cisplatin and standard chemotherapeutic agents. More importantly, anti-tumour activity is demonstrated in vivo, albeit in a mouse model. The presentation will give a brief overview of ?metals in medicine? with a focus on gold and will summarise some recent advances in the development of goldbased anti-tumour agents.